Why is Pharmaids Pharma falling/rising?

As of 04-Sep, Pharmaids Pharmaceuticals Ltd is currently priced at 62.18, reflecting a slight increase of 0.03 (0.05%). The stock has shown a performance inline with its sector today, although it is higher than the 5-day moving average but lower than the 20-day, 50-day, 100-day, and 200-day moving averages. Despite a strong long-term performance with a 55.45% return over the past year and significant gains over the last three years, the company is facing challenges such as operating losses and a high debt-to-EBITDA ratio, which contribute to its weak long-term fundamental strength. Additionally, there has been a notable decline in investor participation, with delivery volume dropping by 66.38% compared to the 5-day average, indicating reduced interest in the stock.
In the broader market context, Pharmaids Pharmaceuticals has outperformed the benchmark Sensex in the short term, with a 2.95% increase over the past week compared to the Sensex's 0.80% rise. However, the stock's year-to-date performance shows a decline of 11.78%, contrasting with the Sensex's gain of 3.30%. This divergence highlights the stock's volatility and the impact of its underlying financial issues, which may deter investors despite its historical performance. Overall, while the stock has seen a minor uptick recently, the combination of weak fundamentals and declining investor interest suggests caution moving forward.